🇺🇸 FDA
Pipeline program

umbilical cord mesenchymal stem cells

UCMSC-4

Phase 2 mab active

Quick answer

umbilical cord mesenchymal stem cells for Cartilage Damage is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Cartilage Damage
Phase
Phase 2
Modality
mab
Status
active

Clinical trials